DaVita HealthCare Partners Inc (DVA) : Alyeska Investment Group scooped up 195,929 additional shares in DaVita HealthCare Partners Inc during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Aug 15, 2016. The investment management firm now holds a total of 1,490,323 shares of DaVita HealthCare Partners Inc which is valued at $103,055,835.DaVita HealthCare Partners Inc makes up approximately 1.01% of Alyeska Investment Group’s portfolio.
Other Hedge Funds, Including , D. E. Shaw reduced its stake in DVA by selling 53,978 shares or 1.87% in the most recent quarter. The Hedge Fund company now holds 2,826,533 shares of DVA which is valued at $195,454,757. DaVita HealthCare Partners Inc makes up approx 0.40% of D. E. Shaw’s portfolio.Oppenheimer Co Inc boosted its stake in DVA in the latest quarter, The investment management firm added 817 additional shares and now holds a total of 26,751 shares of DaVita HealthCare Partners Inc which is valued at $1,874,978. DaVita HealthCare Partners Inc makes up approx 0.05% of Oppenheimer Co Inc’s portfolio.Ncm Capital Management Group Inc reduced its stake in DVA by selling 25 shares or 7.14% in the most recent quarter. The Hedge Fund company now holds 325 shares of DVA which is valued at $25,012. DaVita HealthCare Partners Inc makes up approx 0.30% of Ncm Capital Management Group Inc’s portfolio.Calvert Investment Management boosted its stake in DVA in the latest quarter, The investment management firm added 57 additional shares and now holds a total of 10,300 shares of DaVita HealthCare Partners Inc which is valued at $792,688. DaVita HealthCare Partners Inc makes up approx 0.04% of Calvert Investment Management’s portfolio.
DaVita HealthCare Partners Inc closed down -0.44 points or -0.68% at $64.19 with 23,46,029 shares getting traded on Thursday. Post opening the session at $64.51, the shares hit an intraday low of $63.83 and an intraday high of $64.65 and the price fluctuated in this range throughout the day.Shares ended Thursday session in Red.
On the company’s financial health, DaVita HealthCare Partners Inc reported $1.01 EPS for the quarter, beating the analyst consensus estimate by $ 0.03 according to the earnings call on Aug 8, 2016. Analyst had a consensus of $0.98. The company had revenue of $3718.00 million for the quarter, compared to analysts expectations of $3658.91 million. The company’s revenue was up 8.2% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.95 EPS.
Many Wall Street Analysts have commented on DaVita HealthCare Partners Inc. DaVita HealthCare Partners Inc was Downgraded by BofA/Merrill to ” Neutral” on Sep 6, 2016. DaVita HealthCare Partners Inc was Initiated by Citigroup to “Neutral” on Sep 6, 2016.
DaVita HealthCare Partners Inc. consists of two divisions Kidney Care and HealthCare Partners (HCP). Kidney Care is a provider of dialysis services in the United States treating patients with chronic kidney failure and end stage renal disease (ESRD). Kidney Care division develops innovative clinical care offers integrated treatment plans personalized care teams and health-management services. As of December 31 2014 we provided dialysis and administrative services in the U.S. through a network of 2179 outpatient dialysis centers in 46 states and the District of Columbia serving a total of approximately 173000 patients. HealthCare Partners division is a patient- and physician-focused integrated health care delivery and management company. HealthCare Partners manages and operates medical groups and affiliated physician networks in Arizona California Nevada Florida and New Mexico. As of December 2014 HealthCare Partners had approximately 837000 members under its care.